Skip to main content

Table 4 Demographical, laboratory, and treatment features of type 1 (T1D), type 2 (T2D) and gestational (GDM) diabetic patients

From: Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients

Subjects Age (years) Gender Insulin regular/NPH Duration of diabetes (years) Blood glucose (mg/dL) Glycated hemoglobin (%) Metformin (mg/day) Duration of pregnancy (weeks)
T1DM-02 23 M Yes 13 197 8.3 - -
T1DM-03 24 M Yes 6 260 10 - -
T1DM-04 18 M Yes 8 23 7.2 - -
T1DM-05 23 M Yes 20 178 10.1 - -
T1DM-06 21 F Yes 8 223 7.8 - -
T1DM-12 27 F Yes 10 257 10.4 - -
T1DM-15 22 F Yes 13 143 8.3 - -
Mean ± SD 22.57 ± 2.76    11.14 ± 4.70 183 ± 82.08 8.87 ± 1.27   
T2DM-04 49 M No 8 130 7.5 2550 -
T2DM-05 42 M Yes 11 53 5.1 1700 -
T2DM-09 52 M No 10 100 6.6 1700 -
T2DM-11 41 F Yes 3 92 10.2 2550 -
T2DM-12 43 F No 4 173 10.7 2550 -
T2DM-13 60 F Yes 20 306 10.9 0 -
T2DM-16 56 F Yes 20 295 12 2550 -
T2DM-17 61 F Yes 20 101 7.8 2550 -
Mean ± SD 50.5 ± 8.05    12 ± 7.15 156.25 ± 95.35 8.85 ± 2.43   
GDM-09 33 F No   80 5 - 35
GDM-10 29 F Yes   89 5.8 - 37
GDM-12 39 F No   72 5.7 - 32
GDM-13 29 F Yes   92 5.2 - 28
GDM-14 30 F No   82 5 - 34
GDM-16 38 F Yes   59 9.1 - 34
Mean ± SD 33 ± 4.51     79 ± 12.06 5.96 ± 1.57   33.33 ± 3.07